Find clinical trials for Multiple Myeloma in Orlando, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Orlando, FL, USA:
This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...
Phase 2
Lake Mary, Florida, United States and 16 other locations
Lenalidomide and Dexamethasone (Rd) maintenance in newly diagnosed multiple myeloma participants for whom ASCT is not planned as in...
Phase 3
Orlando, Florida, United States and 135 other locations
The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negat...
Phase 3
Lady Lake, Florida, United States and 173 other locations
and safety of arlo-cel (BMS-986393) versus standard regimens in adult participants with Relapsed or Refractory and Lenalidomide-exposed Multiple...
Phase 3
Tavares, Florida, United States and 133 other locations
This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the ...
Phase 3
Orlando, Florida, United States and 209 other locations
of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response...
Phase 3
Orlando, Florida, United States and 101 other locations
of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response...
Phase 3
Orlando, Florida, United States and 116 other locations
and to further characterize safety and efficacy of an alternative dosing for teclistamab in Part 2 in participants with relapsed or refractory multiple...
Phase 3
Orlando, Florida, United States and 210 other locations
The primary purpose of this study is to assess the efficacy (overall response rate) of subcutaneous (SC) via on body delivery system (SC-OBDS) isatux...
Phase 2
Lake Mary, Florida, United States and 31 other locations
This is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agen...
Phase 1, Phase 2
Lake Mary, Florida, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal